Fitzgerald P H, Beard M E, Morris C M, Heaton D C, Reeve A E
Br J Haematol. 1987 Jul;66(3):311-4. doi: 10.1111/j.1365-2141.1987.tb06915.x.
An analysis of five patients with Philadelphia chromosome (Ph) negative chronic myeloid leukaemia (CML) revealed that two were clinically and haematologically identical to Ph-positive CML whereas three should be reclassified as chronic myelomonocytic leukaemia (CMML). At a molecular level the first two patients showed the same juxtaposition of c-abl and bcr genes as is seen in Ph-positive CML. These genomic changes were not seen in the other three patients. Observations on these five patients suggest that the clinical course and prognosis of the rare patient who carries the Ph 'molecular defect' but lacks the Philadelphia chromosome is no different from Ph-positive CML.
对5例费城染色体(Ph)阴性慢性髓性白血病(CML)患者的分析显示,其中2例在临床和血液学上与Ph阳性CML相同,而另外3例应重新分类为慢性粒单核细胞白血病(CMML)。在分子水平上,前2例患者显示出与Ph阳性CML中所见相同的c-abl和bcr基因并列。在其他3例患者中未观察到这些基因组变化。对这5例患者的观察表明,携带Ph“分子缺陷”但缺乏费城染色体的罕见患者的临床病程和预后与Ph阳性CML无异。